南宫NG·28
About Us
About Us
Group Overview
Management Team
History of Chipscreen Bioscences
Intellectual Property
Honors
Social Responsibility
Our Partners
Research & Development
Research & Development
Core Technologies
Therapeutic Areas
Research & Development System
Product Lifecycle Management
Pipeline
Pipeline
Pipelines
Chidamide
Chiglitazar
Chiauranib
CS12192
CS23546
CS32582
Other Products Under Development
News & Reports
News & Reports
Company News
Media Reports
Notice & Announcement
Video Library
Contact Us
Contact Us
Contact Details
Investor Relations
Patient Care
Working at Chipscreen
CN
EN
Investors
Investors
Company Announcements
Periodic Reports
Patient Care
Patient Care
Safety
Chidamide Donation
Adverse Event/Reaction Reports
Career
Career
Career Development
Career Opportunities
Emplyee Benefits
Employee Growth
Our Staff
CN
Search...
Your browser does not support the video tag.
Other Products Under Development
Home
Pipeline
Other Products Under Development
Chipscreen Biosciences has laid out a number of R&D projects with differentiated advantages and global competitiveness around the five major areas of malignant tumors, metabolic diseases, autoimmune diseases, central nervous system diseases, and antivirals, and stocked a series of candidate drugs, such as CS12088 and CS23074, which are new molecular entities discovered exclusively. These projects/products will also form the core value of Chipscreen Biosciences in the future.
Please scan the QR code below by Wechat and follow the official accounts platform of "Chipscreen Biosciences"to get more information about the latest R&d progress.
Back to List